A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase

被引:287
|
作者
Meyer, PR
Matsuura, SE
Mian, AM
So, AG
Scott, WA [1 ]
机构
[1] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
[2] Univ Miami, Sch Med, Dept Med, Miami, FL 33101 USA
关键词
D O I
10.1016/S1097-2765(00)80185-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in HIV-1 reverse transcriptase (RT) give rise to 3'-azido-3'-deoxythymidine (AZT) resistance by a mechanism that has not been previously reproduced in vitro. We show that mutant RT has increased ability to remove AZTMP from blocked primers through a nucleotide-dependent reaction, producing dinucleoside polyphosphate and extendible primer. In the presence of physiological concentrations of ATP, mutant RT extended 12% to 15% of primers past multiple AZTMP termination sites versus less than 0.5% for wild type. Although mutant RT also unblocked ddAMP-terminated primers more efficiently than wild-type RT, the removal of ddAMP was effectively inhibited by the next complementary dNTP (ICS50 approximate to 12 mu M). In contrast, the removal of AZTMP was not inhibited by dNTPs except at nonphysiological concentrations (ICS50 > 200 mu M).
引用
收藏
页码:35 / 43
页数:9
相关论文
共 50 条
  • [31] Selective primer unblocking of carbovir, lamivudine, tenofovir and zidovudine by wild-type HIV reverse transcriptase with nucleotide and deoxynucleotide triphosphates
    Gerondelis, P
    Underwood, MR
    Lanier, ER
    ANTIVIRAL THERAPY, 2004, 9 (04) : U37 - U38
  • [32] Mechanisms of resistance associated with excision of incorporated nucleotide analogue inhibitors of HIV-1 reverse transcriptase
    Goette, Matthias
    CURRENT OPINION IN HIV AND AIDS, 2007, 2 (02) : 103 - 107
  • [33] Synthesis of AZT 5′-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase
    Wang, GY
    Boyle, N
    Chen, F
    Rajappan, V
    Fagan, P
    Brooks, JL
    Hurd, T
    Leeds, JM
    Rajwanshi, VK
    Jin, Y
    Prhavc, M
    Bruice, TW
    Cook, PD
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) : 6902 - 6913
  • [34] Synergistic inhibition of HIV-1 reverse transcriptase and HIV-1 replication by combining trovirdine with AZT, ddl and ddC in vitro
    Zhang, H
    Vrang, L
    Rydergard, C
    Ahgren, C
    Oberg, B
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1996, 7 (05): : 221 - 229
  • [35] Effects of primer-template sequence on ATP-dependent removal of chain-terminating nucleotide analogues by HIV-1 reverse transcriptase
    Meyer, PR
    Smith, AJ
    Matsuura, SE
    Scott, WA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) : 45389 - 45398
  • [36] A biochemical look into the nucleotide binding site of HIV-1 reverse transcriptase
    Menéndez-Arias, L
    Cases-González, CE
    Gutiérrez-Rivas, M
    FIFTH EUROPEAN CONFERENCE ON EXPERIMENTAL AIDS RESEARCH (ECEAR 2000), 2000, : 1 - 9
  • [37] Allosteric Regulation of HIV-1 Reverse Transcriptase by ATP for Nucleotide Selection
    Yokoyama, Masaru
    Mori, Hiromi
    Sato, Hironori
    PLOS ONE, 2010, 5 (01):
  • [38] Efavirenz alters the interaction between HIV-1 reverse transcriptase and template/primer
    Radzio, J.
    Sheen, C.-W.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S133 - S133
  • [39] Efavirenz alters the interaction between HIV-1 reverse transcriptase and template/primer
    Radizio, J.
    Sheen, C-W
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2007, 12 : S133 - S133
  • [40] TEMPLATE PRIMER INTERACTIONS WITH RECOMBINANT FORMS OF HIV-1 REVERSE-TRANSCRIPTASE
    BEARD, WA
    KUMAR, A
    WILSON, SH
    FASEB JOURNAL, 1992, 6 (01): : A357 - A357